Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABCTx trial of methimazole with or without colestimide for newly diagnosed childhood-onset Graves' disease
jRCTs031180108Completed
- Sponsor
- Ministry of Education, Culture, Sports, Science and Technology
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in Graves' disease comparing Methimazole + colestimide with Methimazole monotherapy (2 arms). Primary endpoint: Normalization rate of free T4 and free T3 at 4 weeks. Started Oct 2014; status: completed.
02
Drugs
methimazolecolestilan
03
Conditions
Graves' disease
Beyond the preview
Go deeper on jRCTs031180108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180108.